Trulicity 0.75mg Injection

Trulicity (dulaglutide) 0.75 mg injection is a medication used for the management of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which help to lower blood sugar levels.

Indications:

• Treatment of type 2 diabetes in adults, often in conjunction with diet and exercise.
• May be used alone or in combination with other antidiabetic medications.

Dosage:

• The typical starting dose is 0.75 mg once a week. Depending on the patient's response, the dose may be increased to 1.5 mg once a week.

Mechanism of Action:

Trulicity mimics the effects of the GLP-1 hormone, which:

• Increases insulin secretion in response to meals
• Reduces glucagon secretion
• Slows gastric emptying, leading to increased satiety

Side Effects:

Common side effects may include:

• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Decreased appetite

Serious side effects may include:

• Risk of pancreatitis
• Hypoglycemia (especially when combined with other diabetes medications)

Precautions:

• Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• Monitor for signs of pancreatitis and discuss any previous gastrointestinal issues with a healthcare provider.